Letermovir Vs High Dose Valacyclovir for Cytomegalovirus Prophylaxis Following Haploidentical Allogeneic Hematopoietic Transplantation

Craig W. Freyer(Hospital of the University of Pennsylvania), Alison W. Loren(University of Pennsylvania), Daria V. Babushok(Hospital of the University of Pennsylvania), Selina M. Luger(University of Pennsylvania), Shannon Gier(University of Pennsylvania), James K. Mangan(UC San Diego Health System), Mindy G. Schuster(Unknown), Edward A. Stadtmauer(University of Pennsylvania), Alexander E. Perl(University of Pennsylvania), Saar Gill(Parker Institute for Cancer Immunotherapy), Jacqueline Smith(Roslin Institute), Keith W. Pratz(University of Pennsylvania), David L. Porter(Chapman University), Shannon R. McCurdy(Hospital of the University of Pennsylvania), Colleen Timlin(Hospital of the University of Pennsylvania), Alison Carulli(Hospital of the University of Pennsylvania), Noelle V. Frey(Hospital of the University of Pennsylvania), Alex Ganetsky(Hospital of the University of Pennsylvania), Elizabeth O. Hexner(University of Pennsylvania), Mary Ellen Martin(University of Pennsylvania)
Transplantation and Cellular Therapy
January 30, 2021
Cited by 0


Related Papers